IRIS

Lebbe, C., Weber, J., Maio, M., Neyns, B., Harmankaya, K., Chin, K., et al. (2012). Five-Year survival Rates for patients (PTS) with metatastatic melanoma(MM) treated with ipilimumab (IPI) in phase II trials. ASIA PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8(Supplement 3), 309-309.

Five-Year survival Rates for patients (PTS) with metatastatic melanoma(MM) treated with ipilimumab (IPI) in phase II trials

Maio M;
2012-01-01
2012
Lebbe, C., Weber, J., Maio, M., Neyns, B., Harmankaya, K., Chin, K., et al. (2012). Five-Year survival Rates for patients (PTS) with metatastatic melanoma(MM) treated with ipilimumab (IPI) in phase II trials. ASIA PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8(Supplement 3), 309-309.
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1081105